10-K Filing

Company

INTEGRATED BIOPHARMA INC

Filed

September 30, 2013

Period of Report

June 30, 2013

Accession Number

0001016504-13-000011

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →